Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始接受秋水仙显转而接受氨苯砜的患者应当继续服用秋水仙。